Cargando…
BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells
Chemotherapy is a standard treatment for non-small-cell lung cancer (NSCLC). However, the dose-limiting toxicity of drugs and the development of chemoresistance are major clinical challenges to successful management of NSCLC. Asian traditional medicine is gaining global attention as a non-toxic alte...
Autores principales: | Kwon, Taeho, Chandimali, Nisansala, Huynh, Do Luong, Zhang, Jiao Jiao, Kim, Nameun, Bak, Yesol, Yoon, Do-Young, Yu, Dae-Yeul, Lee, Jae Cheol, Gera, Meeta, Ghosh, Mrinmoy, Park, Yang Ho, Jeong, Dong Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833813/ https://www.ncbi.nlm.nih.gov/pubmed/29445170 http://dx.doi.org/10.1038/s41419-018-0277-7 |
Ejemplares similares
-
BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling
por: Huynh, Do Luong, et al.
Publicado: (2019) -
MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells
por: Koh, Hyebin, et al.
Publicado: (2017) -
BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer
por: Chandimali, Nisansala, et al.
Publicado: (2020) -
The Novel Nutraceutical KJS018A Prevents Hepatocarcinogenesis Promoted by Inflammation
por: Huynh, Do Luong, et al.
Publicado: (2018) -
Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma
por: MONGRE, RAJ KUMAR, et al.
Publicado: (2015)